Therefore, treatments aimed at affecting ciliary functions in our experiments, such as SHH/cyclopamine and dnKif3a expression, most likely affected most/all of the GBM cells during the ciliated stage of their cell cycle. This evidence concerns the gene SHH and glioblastoma.